Cytokine Adsorption in Critically Ill COVID-19 Patients, a Case-Control Study.

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Immunology

Background:

• COVID-19, an international emergency, frequently leads to multiple organ failure in intensive care unit (ICU) patients.
• Blood purification techniques, including cytokine removal, are being explored for managing critically ill COVID-19 patients.
• Cytokine adsorption aims to modulate the immune response in severe inflammatory conditions.

Purpose of the Study:

• To investigate the role and efficacy of cytokine removal using resin membranes in COVID-19 patients admitted to the ICU.
• To evaluate the impact of cytokine filtration on clinical severity scores, laboratory variables, and patient outcomes, including mortality.

Main Methods:

• A case-control study involving 72 COVID-19 patients managed in ICUs.
• Patients were divided into a Cytokine Filtration (CF) group (n=36) and a Case-Control (CC) group (n=36).
• Cytokine removal was performed using HA330 and Mediasorb resin membranes; clinical and laboratory data were tracked over time.

Main Results:

• Mortality rates were similar between groups: 55.6% in the CF group and 50% in the CC group.
• In the CF group, significant reductions in C-reactive protein (CRP) and fibrinogen were observed post-treatment.
• Lymphocyte counts increased, and neutrophil ratios decreased in the CF group, but other laboratory variables and SOFA scores showed no significant differences.

Conclusions:

• Cytokine adsorption in critically ill COVID-19 patients led to favorable changes in inflammatory markers (CRP, fibrinogen) and lymphocyte counts.
• Despite these laboratory improvements, cytokine filtration did not demonstrate a significant clinical benefit, including a reduction in mortality or length of stay.
• While there is a pathophysiological rationale for cytokine adsorption, current evidence is insufficient to strongly recommend its use for immunomodulation in severe COVID-19.